Both TRAF-1 and C5 are excellent candidate genes for perpetuating inflammation in RA; however, other evidence implicates the complement terminal pathway in RA pathogenesis, including identification of TCC in diseased joints, joint fluid and plasma of RA patients [64]. Here, C5 is linked to rheumatoid arthritis.